Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Effects of intermittent fasting and exercise on inflammation and metabolism in metabolic syndrome

Official title: Effects of Intermittent Fasting and Its Combination with High-Intensity Interval Training on Inflammatory and Metabolic Markers, As Well As the Microbiome in Patients with Metabolic Syndrome: a Randomized Controlled Pilot Study

Run by University of Erlangen-Nürnberg Medical School · NCT06885255 · Data updated 2026-11-12

This study is testing if intermittent fasting alone or with high-intensity exercise can reduce inflammation and improve metabolism in people with obesity and metabolic syndrome.

More Metabolic Syndrome trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment250 (estimated)
SponsorUniversity of Erlangen-Nürnberg Medical School
Academic / other
Locations1 site (Erlangen, Bavaria)
StatusRecruiting
StartedJune 1, 2023
Main results expectedDecember 2025
Study endsMarch 2026
Registry record updatedMarch 20, 2025
Trial IDNCT06885255 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older diagnosed with metabolic syndrome and elevated hsCRP levels.

Probably not a fit

Patients with cardiovascular diseases, orthopedic restrictions, or those who are pregnant or nursing may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention assesses how intermittent fasting, both alone and combined with high-intensity interval training, impacts inflammation and metabolism in individuals with obesity and metabolic syndrome. Participants will engage in a 3-month fasting regimen, with one group also participating in high-intensity interval training twice a week. The study includes control groups of individuals with metabolic syndrome and healthy individuals, and it features multiple in-house visits for assessments and nutritional counseling over a total of 6 months.

Why it matters

Potential benefit: If successful, this study could provide new strategies for managing obesity and metabolic syndrome through lifestyle interventions.

How similar studies have gone: Other studies have shown promising results with intermittent fasting and exercise in similar populations, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Written consent to participate in the study.
* Persons aged 18 years and older.
* Diagnosis of Metabolic Syndrome (MetS) with elevated hsCRP.

Exclusion Criteria:

* Pregnant or nursing individuals.
* Cardiovascular diseases or orthopedic restrictions that prevent exercise.
* Use of medication or supplements that significantly affect study outcomes (e.g., anti-inflammatory medications, antibiotics within the last 6 weeks).
* Body weight greater than 200 kg (maximum capacity of training equipment).
* Individuals with mental illnesses that may impair their ability to understand or participate in the study.

Where it's running

  • Hector-Center for Nutrition, Exercise and Sports, University Hospital Erlangen
    Erlangen, Bavaria, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.